Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital Outpatient Care for Patients With Type 1 Diabetes (DigiDiaS): Pragmatic Observational Pre-Post Study.

Journal of medical Internet research·2026
Same author

Bridging Objective and Subjective Data: A Comprehensive Architecture for Wearable Health Research.

Studies in health technology and informatics·2026
Same author

Kernel Density Estimation of Wearable Signals to Predict Preoperative Cancellation Risk.

Studies in health technology and informatics·2026
Same author

Experiences from Multi-Method Testing of a Comprehensive Mobile Health App.

Studies in health technology and informatics·2026
Same author

Sustainability in Food-Based Dietary Guidelines: Digital Readiness in Nordic Versus Mediterranean Countries.

Studies in health technology and informatics·2026
Same author

Recommendations for Establishing a Master's Degree in Digital Health Services.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: May 18, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Mobile phone-based pattern recognition and data analysis for patients with type 1 diabetes.

Stein Olav Skrøvseth1, Eirik Årsand, Fred Godtliebsen

  • 1Norwegian Centre for Integrated Care and Telemedicine, University Hospital of North Norway, Tromsø, Norway.

Diabetes Technology & Therapeutics
|October 6, 2012
PubMed
Summary

Mobile apps help type 1 diabetes patients manage blood glucose by collecting self-gathered data. Analysis reveals patterns, offering data-driven insights for improved disease management.

More Related Videos

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
06:00

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 18, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
06:00

Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen

Published on: January 26, 2024

Area of Science:

  • Digital Health
  • Diabetes Management
  • Mobile Health Interventions

Background:

  • Type 1 diabetes patients generate substantial data via electronic self-help tools.
  • Mobile phones offer potential for analyzing personal health data.
  • Exploring self-gathered data's role in improving blood glucose management is crucial.

Purpose of the Study:

  • To investigate how self-gathered data, collected via mobile applications, can enhance blood glucose management for individuals with type 1 diabetes.

Main Methods:

  • Thirty patients with type 1 diabetes used a mobile app for 3-6 months, recording blood glucose, insulin, diet, activity, and symptoms.
  • Data analysis focused on module usage and developing data processing/visualization tools.
  • Utilized period finding and scale-space trends for pattern identification.

Main Results:

  • Eighteen patients ('adopters') provided complete data for over 80 days.
  • Common reasons for withdrawal included phone usability issues.
  • Pattern recognition for predicting glucose levels showed poor performance, but trend analysis identified significant patterns for most adopters.

Conclusions:

  • Minimally intrusive mobile applications empower type 1 diabetes users to record data.
  • This data can offer valuable, data-driven insights for disease self-management.
  • Mobile health tools show potential for personalized diabetes care.